Singapore: Charles River Laboratories has appointed Mr John Crowley to the role of corporate senior VP, corporate contro...
Singapore: Clinical stage biopharmaceutical company, Ambrx and China's Zhejiang Medicine (ZMC) have formed a collaborati...
Human serum albumin (HSA), a blood protein that is widely used in drug and vaccine production, is in high demand around ...
Singapore: BGI-Shenzhen (BGI) announced that it, through its wholly owned subsidiary Beta Acquisition, has extended its...
Singapore: China Botanic Pharmaceutical (formerly Renhuang Pharmaceuticals) received a warning letter from the NYSE MKT...
Yunnan Baiyao made new strategies for 2011 and the year recorded relocation, expansion of the company's business develop...
Singapore: China-based Biostar Pharmaceuticals signed a one-year agreement, valued at approximately $3.0 million, to man...
Singapore: The not-for-profit organization, International Medica Foundation, that works towards the development of a saf...
Singapore: Kinex Pharmaceuticals executed a license agreement with Xiangxue Pharmaceuticals granting Xiangxue Pharmaceut...
Singapore: A map of avian influenza (H7N9), comprising of bird migration patterns and estimations of poultry production ...
China's role in the global drug industry will fundamentally change; most companies will fail to capitalize on this oppor...
Singapore: Japanese major Takeda Pharmaceutical has said that the China's State Food and Drug Administration (SFDA) has ...
Clocking $1.3 billion revenue in 2012, Guangzhou Pharmaceutical recorded a growth of over 50 percent. A well-recognize...
The bioscience industry is about to step into 2013 and the year is predicted to unfold with new opportunities and trends...
Singapore: Zoetis, which is the animal health business of Pfizer, received approval by Chinese Ministry of Agriculture f...
Singapore: Global clinical supply chain solutions provider, Marken, appointed Ms Joan Yan as its new general manager for...
The number of mergers and acquisitions (M&A) that have been made over the past two years have almost returned to pre...
Most pharmaceutical companies are sitting on the patent cliff and their drug pipelines are facing severe exhaustion. The...
